RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Eton Pharmaceuticals Stock

Eton Pharmaceuticals Market capitalization 2024

Eton Pharmaceuticals Market capitalization

116.43 M USD

Ticker

ETON

ISIN

US29772L1089

WKN

A2N38G

In 2024, Eton Pharmaceuticals's market cap stood at 116.43 M USD, a 0.33% increase from the 116.04 M USD market cap in the previous year.

The Eton Pharmaceuticals Market capitalization history

YEARMarket Capitalization (undefined USD)
202397.49
202278.19
2021176.22
2020133.32
2019121
2018108.02
2017-

Eton Pharmaceuticals Aktienanalyse

What does Eton Pharmaceuticals do?

The company Eton Pharmaceuticals Inc is an innovative company that specializes in the development of high-quality and reliable medications. The company was founded in 2017 in Deer Park, Illinois, and has since become a leading company in the pharmaceutical industry. Eton Pharmaceuticals Inc's business model is closely related to the development of new medications. The company specializes in the development of so-called "gel-coated" medications, which have better efficacy and tolerability than conventional medications. The company uses innovative and patented technologies to overcome the current limitations of medications and provide customers with the best possible treatment. Eton Pharmaceuticals Inc has different divisions for the development of medications. One of the most important divisions is oncology, where medications for tumor treatment are developed. The company relies on innovative approaches to discover new active substances and improve the treatment of cancer patients. In addition, the company has extensive experience in the production of antibiotics. Eton Pharmaceuticals Inc has developed its own products tailored to the needs of patients, promising fast and effective effects. The company has also developed special medications for the treatment of cardiovascular diseases, aiming to provide patients with a better quality of life. One of the products offered by Eton Pharmaceuticals Inc is the medication "BML-190". This medication is an anti-inflammatory drug used for pain and inflammation. Its special feature is its high effectiveness with minimal side effects, which often occur with other medications. Another product of Eton Pharmaceuticals Inc is the medication "DS-300", used for certain eye diseases. The medication contains an active substance that acts on the eyes and allows for quick healing. Thanks to the innovative technology used in its development, this medication is well tolerated and has minimal side effects. Overall, Eton Pharmaceuticals Inc is an innovative company specializing in the development of high-quality medications. With its business model and expertise in various areas of the pharmaceutical industry, the company is well equipped to continue making significant contributions to healthcare. Eton Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Market capitalization Details

Exploring Eton Pharmaceuticals's Market Capitalization

Eton Pharmaceuticals's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Eton Pharmaceuticals's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Eton Pharmaceuticals's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Eton Pharmaceuticals’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Eton Pharmaceuticals stock

What is the current Eton Pharmaceuticals market capitalization?

The current market capitalization of Eton Pharmaceuticals is 116.43 M USD.

What is market capitalization?

The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Eton Pharmaceuticals.

How has the market capitalization of Eton Pharmaceuticals developed in recent years?

The market capitalization of Eton Pharmaceuticals has increased/decreased by 0.33% compared to the previous year.

What does market capitalization mean for investors?

The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.

Why is market capitalization an important indicator for investors?

The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.

Why does the market capitalization fluctuate?

The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.

What role does market capitalization play in the valuation of Eton Pharmaceuticals?

In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.

Does the market capitalization influence the performance of Eton Pharmaceuticals?

There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

Does the market capitalization of Eton Pharmaceuticals have an influence on indices?

Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).

How much dividend does Eton Pharmaceuticals pay?

Over the past 12 months, Eton Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Eton Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Eton Pharmaceuticals?

The current dividend yield of Eton Pharmaceuticals is .

When does Eton Pharmaceuticals pay dividends?

Eton Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Eton Pharmaceuticals?

Eton Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Eton Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Eton Pharmaceuticals located?

Eton Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Eton Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Eton Pharmaceuticals from 8/26/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 8/26/2024.

When did Eton Pharmaceuticals pay the last dividend?

The last dividend was paid out on 8/26/2024.

What was the dividend of Eton Pharmaceuticals in the year 2023?

In the year 2023, Eton Pharmaceuticals distributed 0 USD as dividends.

In which currency does Eton Pharmaceuticals pay out the dividend?

The dividends of Eton Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Eton Pharmaceuticals

Our stock analysis for Eton Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Eton Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.